Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

HACKSENSACK, NJ / ACCESSWIRE / September 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global provider of preclinical and clinical research services, delivering end-to-end oncology solutions, today announced financial results for its first …

HACKSENSACK, NJ / ACCESSWIRE / September 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global provider of preclinical and clinical research services, delivering end-to-end oncology solutions, today announced financial results for the first quarter of its fiscal year 2025, ended July 31, 2024.

First quarter highlights:

We are a standout news service and fast becoming a disruptor in the industry. We deliver regional, national and global news to thousands of customers worldwide. We are also leaders in social engagement, targeting and analytics.